Bob, Burger called it a "stock consolidation" to meet the requirements of a listed exchange. It is not something immediately planned but something they would do after gaining FDA approval on a product or signing a third licensee along with a cash flow positive balance sheet.
I have never heard anything good about reverse splits. Why Dr. Burger is raising that option is beyond me. If he's so confident about future cash flow and the potential of RECAF, then let Biocurex drop the share count with stock buy-backs.
News 
Market Data 
Discover 
